格隆匯港股回購榜 | 5月6日
格隆匯勾股大數據顯示,中國平安(02318)、友邦保險(01299)、廣發證券(01776)、京東健康(06618)、創維集團(00751)、長實集團(01113)、中國飛鶴(06186)、中國軟件國際(00354)、創夢天地(01119)、國泰君安國際(01788)、民銀資本(01141)、聯易融科技-W(09959)、康臣藥業(01681)、賽晶科技(00580)、賽生藥業(06600)、順誠(00531)、復旦張江(01349)、億和控股(00838)、彩客化學(01986)、科通芯城(00400)、匯豐控股(00005)、清科創業(01945)、美瑞健康國際(02327)、永勝醫療(01612)、福森藥業(01652)、康聖環球(09960)、和諧汽車(03836)、天福(06868)、新鴻基公司(00086)、摩比發展(00947)於2022年05月06日進行了回購。其中,回購金額最大的為中國平安(02318),回購數量618.63萬 ,回購金額2.74億。
備註:以上數據由格隆匯數據中心根據港交所數據加工計算所得,並不保證100%精確。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.